Logo

AstraZeneca To Supply 400M Doses of Vaccines to IVA by the End of 2020

Share this

AstraZeneca To Supply 400M Doses of Vaccines to IVA by the End of 2020

Shots:

  • AstraZeneca has signed an agreement with EU’s IVA- spearheaded by Germany- France- Italy- and the Netherlands- to supply up to 400M doses of the University of Oxford’s AZD1222- with deliveries starting by the end of 2020
  • The collaboration allows IVA to accelerate the supply of the vaccine and to provide equitable access to all participating countries across the EU
  • Additionally- AstraZeneca had signed a similar kind of agreement with US- UK- CEPI- GAVI for $700M doses- and collaborated with SII for 1B doses. Last month- Oxford University has initiated P- II/III UK trial of AZD1222 in ~10-000 adult volunteers

Click here to read full press release/ article 

Ref: AstraZeneca | Image: Barrons

 


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions